Lab members

• Clara Nahmias (DR CNRS, HDR)
• Adam Telerman (MD, DRCN CNRS)
• Olivia Fromigué (CRCN-HDR INSERM)
• Anna Rocca (CRCN CNRS)
• Robert Amson (MD, researcher)
• Sylvie Rodrigues-Ferreira (researcher, Innovarion)
• Catherine Genestie (Pathologist, GRCC)
• Magali Lacroix-Triki (MD, PhD, Pathologist)
• Alexandra Leary (MD, PhD, GRCC)
• Etienne Rouleau (MD, PhD, GRCC)
• Inés Vaz-Luis (MD, PhD)
• Jean-Charles Ahomadegbe (MCU Amiens, HDR)
• Tony Sourisseau (Engineer, GRCC)

Major publications

• Bertucci F, Ng CKY, Patsouris A, Droin N, Piscuoglio S, Carbuccia N, Soria JC, Dien AT, Adnani Y, Kamal M, Garnier S, Meurice G, Jimenez M, Dogan S, Verret B,Chaffanet M, Bachelot T, Campone M, Lefeuvre C, Bonnefoi H, Dalenc F, Jacquet A, De Filippo MR, Babbar N, Birnbaum D, Filleron T, Le Tourneau C, André F. Genomic characterization of metastatic breast cancers. Nature. 2019

Molecular caracterization of breast and gynecologic cancers

This team belongs to the UMR 981 - Molecular predictors and new targets in oncology

Gustave Roussy takes care to ensure that the administrative formalities for you within the hospital are simple.
The administrative formalities unit is there to answer your questions and, if necessary, to help you. This unit works closely with the Gustave Roussy social services unit.

Treatment costs are usually high. If you have French social security or if your country is signatory to a reciprocal agreement with France, these costs are wholly or partially covered.

Patients are first and foremost citizens and, as such, possess rights. These protect and ensure their autonomy and respect of their individual freedoms and dignity within the hospital. Communication with patients plays a fundamental role in their management and allows them to participate fully in decisions about their treatment.    

The haematopoietic niche group